Robotic Left Minor Liver Resection With the Hugo™ RAS System: Initial Experience

IntroductionMinimally invasive liver resection has become an established approach in selected patients, offering reduced blood loss, lower morbidity, and faster recovery compared with open surgery. The recent introduction of new robotic systems, such as the Hugo™ RAS (Medtronic), has expanded the potential of robotic hepatobiliary surgery. This study reports the first clinical experience with robotic liver resection (RLR) performed using the Hugo™.MethodsA prospective case series was conducted at a tertiary referral centre, including the first 3 consecutive patients who underwent robotic liver resection for colorectal liver metastases (CRLM) between April and June 2025. Demographic, perioperative, and oncological data were collected and analyzed descriptively. All procedures were performed by experienced hepatobiliary surgeons using the Hugo™ RAS platform.ResultsThree patients (2 males; median age 84 years) underwent minor hepatectomies: 2 left lateral sectionectomies (segments II-III) and one combined non-anatomical resection of segments II-III-IVb with cholecystectomy. All operations were completed robotically without conversion. The median operative time was 210 minutes (range 180-240), median docking time was 15 minutes, and median blood loss was 50 mL (range 50-100). No intraoperative complications occurred. Median hospital stay was 4 days (range 3-5). No postoperative complications or readmissions were recorded at 30- and 90-day follow-up. All specimens achieved R0 margins.ConclusionsRLR using the Hugo™ RAS system is feasible and safe in selected minor hepatectomies.

Authors

Institutions

Publication Details

Journal
Surgical Innovation
Published
2026-04-13
DOI
https://doi.org/10.1177/15533506261442269
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Robotic Left Minor Liver Resection With the Hugo™ RAS System: Initial Experience

Salvadora Delgado‐Rivilla, Judith Camps-Lasa, María Galofré-Recasens, M I García-Domingo et al.
Surgical Innovation
Hepatocellular Carcinoma Treatment and Prognosis
article

Robotic Left Minor Liver Resection With the Hugo™ RAS System: Initial Experience

Salvadora Delgado‐Rivilla, Judith Camps-Lasa, María Galofré-Recasens, M I García-Domingo, Eric Herrero Fonollosa, Salvador Llopis-Mestre, Qiaomiao Lin, Ana Alcaine-DelRio
article en

Abstract

IntroductionMinimally invasive liver resection has become an established approach in selected patients, offering reduced blood loss, lower morbidity, and faster recovery compared with open surgery. The recent introduction of new robotic systems, such as the Hugo™ RAS (Medtronic), has expanded the potential of robotic hepatobiliary surgery. This study reports the first clinical experience with robotic liver resection (RLR) performed using the Hugo™.MethodsA prospective case series was conducted at a tertiary referral centre, including the first 3 consecutive patients who underwent robotic liver resection for colorectal liver metastases (CRLM) between April and June 2025. Demographic, perioperative, and oncological data were collected and analyzed descriptively. All procedures were performed by experienced hepatobiliary surgeons using the Hugo™ RAS platform.ResultsThree patients (2 males; median age 84 years) underwent minor hepatectomies: 2 left lateral sectionectomies (segments II-III) and one combined non-anatomical resection of segments II-III-IVb with cholecystectomy. All operations were completed robotically without conversion. The median operative time was 210 minutes (range 180-240), median docking time was 15 minutes, and median blood loss was 50 mL (range 50-100). No intraoperative complications occurred. Median hospital stay was 4 days (range 3-5). No postoperative complications or readmissions were recorded at 30- and 90-day follow-up. All specimens achieved R0 margins.ConclusionsRLR using the Hugo™ RAS system is feasible and safe in selected minor hepatectomies.

Surgical Innovation
Mútua Terrassa (ES)
Good health and well-being
Openalex Percentile: Top 19%
Hepatocellular Carcinoma Treatment and Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.